Authors
Loading...
Analysis reveals decreasing mortality rates from non-hodgkin lymphoma, indicating targeted treatment strategies are needed for high-risk populations.
Khan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: